Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 4 SUPPL. 1, 2000, Pages

  Golino, Paolo ^a   Ragni, M ^a   Cirillo, P ^a   D'Andrea, D ^a   Ravera, M ^a   Calabro, P ^a   Ezban, M ^b   Tommasini, P ^a   Chiariello, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Infarct size; Recombinant active site blocked activated factor VII (rFVIIai); Recombinant factor VIIa (rFVIIa); Reperfusion injury; Thrombosis; Tissue factor

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CAROTID ARTERY OBSTRUCTION; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENDOTHELIUM INJURY; HEART INFARCTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; THROMBOGENESIS;

EID: 0034039624     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200004001-00028     Document Type: Conference Paper

References (20)

1. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992; 326: 800-806.
2. Rapaport SI, Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-1121.
3. Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, et al. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994; 74: 56-63.
4. Wilcox JN, Smith KM, Schwartz S, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
5. Annex BH, Denning SM, Channon KM, Sketch MH, Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-622.
6. Colucci MG, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-1896.
7. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin-1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460-3465.
8. Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 1996; 2: 35-41.
9. Golino P, Ambrosio G, Pascucci I, Ragni M, Russolillo E, Chiariello M. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation. Thromb Haemost 1992; 67: 302-305.
10. Golino P, Cappelli-Bigazzi M, Ambrosio G, Ragni M, Russolillo E, Condorelli M, Chiariello M. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation. Circ Res 1992; 71: 1447-1456.
11. Golino P, Ragni M, Cirillo P, Pascucci I, Ezekowitz MD, Pawashe A, et al. Aurintricarboxylic acid reduces platelet deposition in stenosed and endothelially injured rabbit carotid arteries more effectively than other antiplatelet interventions. Thromb Haemost 1995; 74: 974-980.
12. Golino P, Maroko PR, Carew TE. The effects of acute hypercholesterolemia on myocardial infarct size and the noreflow phenomenon during coronary occlusion-reperfusion. Circulation 1987; 75: 292-298.
13. Golino P, Ambrosio G, Villari B, Ragni M, Focaccio A, Pace L, et al. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion. J Am Coll Cardiol 1993; 21: 493-501.
14. Kowallik P, Schultz R, Guth BD, Schade A, Paffhausen W, Gross R, Heusch G. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 1991; 83: 974-982.
15. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, McVey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782-9787.
16. Lefkovits J, Topol EJ. Direct thrombin inhibitors in cardiovascular medicine. Circulation 1994; 90: 1522-1536.
17. Topol EJ, Bonan R, Jewitt D, Sigwart U, Kakkar VV, Rothman M, et al. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation 1993; 87: 1622-1629.
18. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
19. Forrester JS. New standard for success of thrombolytic therapy. Circulation 1996; 92: 2026-2028.
20. Ragni M, Cirillo P, Pascucci I, Scognamiglio A, D'Andrea D, Eramo N, et al. A monoclonal antibody against tissue factor shortens tissue-plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation 1996; 93: 1913-1920.